-
2018: This Year in Cancer NewsThe Cancer Today editorial staff selects some of the most interesting and impactful reporting, research and perspectives of 2018.
by Cancer Today Staff
-
December 21: The Week in Cancer NewsJudicial threats to the Affordable Care Act continue, and a study investigates the long-term risks of chemotherapy.
by Kate Yandell and Marci A. Landsmann
-
The Education of a Patient AdvocateBob Riter explains how his breast cancer diagnosis set him on a path to find his calling.
by Bob Riter
-
Caregivers Need Support TooHigh-intensity cancer caregiving is associated with poor mental health, especially for caregivers who don't feel they're getting the support services they need.
by Jen Tota McGivney
-
December 14: The Week in Cancer NewsA long-term trial presents new evidence on who should have surgery for localized prostate cancer, and a review finds that women are temporarily at increased risk of breast cancer after giving birth.
by Kate Yandell
-
2018 SABCS: Choosing the Right TreatmentStudies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.
by Kate Yandell
-
December 7: The Week in Cancer NewsA trial tests a new treatment for some patients with early-stage breast cancer, and studies assess how long the benefits of CAR-T cell therapy last for patients with non-Hodgkin lymphoma.
by Kate Yandell
As people with advanced disease live longer, they face physical and mental health side effects. Patient advocates say research and care must focus on their unique needs.
by Thomas Celona
Family of Henrietta Lacks Works for ‘Health Intelligence’Alfred Lacks Carter Jr. and other family members honor the legacy of Henrietta Lacks by helping others better understand their health care.
by Kevin McLaughlin
Researchers Tackle Immune-related Adverse EffectsScientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
